At the end of the 20th century active immunization against hepatitis A
and B has been introduced into routine medical practice. Therefore, p
atients at risk, and especially those with coagulation disorders, shou
ld be immunized at the earliest age possible. In contrast, development
of an efficacious vaccine against hepatitis C remains an important go
al for the next decade.